FRESENIUS MEDICAL CARE-ADR (FMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:FMS - US3580291066 - ADR
23.99 USD
+0.03 (+0.13%)
FMS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FMS get a neutral evaluation. Nothing too spectacular is happening here. FMS may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year FMS was profitable.
In the past year FMS had a positive cash flow from operations.
Each year in the past 5 years FMS has been profitable.
In the past 5 years FMS always reported a positive cash flow from operatings.
1.2 Ratios
FMS has a Return On Assets (2.33%) which is in line with its industry peers.
FMS's Return On Equity of 5.55% is fine compared to the rest of the industry. FMS outperforms 60.78% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.95%, FMS is in line with its industry, outperforming 50.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for FMS is significantly below the industry average of 9.61%.
The last Return On Invested Capital (3.95%) for FMS is above the 3 year average (3.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
FMS's Profit Margin of 3.66% is fine compared to the rest of the industry. FMS outperforms 72.55% of its industry peers.
In the last couple of years the Profit Margin of FMS has declined.
The Operating Margin of FMS (7.19%) is better than 71.57% of its industry peers.
FMS's Operating Margin has declined in the last couple of years.
FMS's Gross Margin of 25.00% is in line compared to the rest of the industry. FMS outperforms 50.00% of its industry peers.
In the last couple of years the Gross Margin of FMS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FMS is destroying value.
FMS has about the same amout of shares outstanding than it did 1 year ago.
FMS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for FMS has been reduced compared to a year ago.
2.2 Solvency
FMS has an Altman-Z score of 1.80. This is a bad value and indicates that FMS is not financially healthy and even has some risk of bankruptcy.
FMS has a Altman-Z score (1.80) which is comparable to the rest of the industry.
FMS has a debt to FCF ratio of 5.97. This is a neutral value as FMS would need 5.97 years to pay back of all of its debts.
FMS has a Debt to FCF ratio of 5.97. This is in the better half of the industry: FMS outperforms 61.76% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that FMS is somewhat dependend on debt financing.
The Debt to Equity ratio of FMS (0.73) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 1.8 |
ROIC/WACC0.78
WACC5.06%
2.3 Liquidity
A Current Ratio of 1.36 indicates that FMS should not have too much problems paying its short term obligations.
FMS has a Current ratio (1.36) which is comparable to the rest of the industry.
A Quick Ratio of 1.00 indicates that FMS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.00, FMS is doing worse than 65.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.77% over the past year.
Measured over the past years, FMS shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.43% on average per year.
FMS shows a small growth in Revenue. In the last year, the Revenue has grown by 2.10%.
FMS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
Based on estimates for the next years, FMS will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.73% on average per year.
The Revenue is expected to grow by 4.08% on average over the next years.
EPS Next Y21.52%
EPS Next 2Y12.88%
EPS Next 3Y13.2%
EPS Next 5Y13.73%
Revenue Next Year1.57%
Revenue Next 2Y2.24%
Revenue Next 3Y2.92%
Revenue Next 5Y4.08%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
FMS is valuated reasonably with a Price/Earnings ratio of 10.86.
FMS's Price/Earnings ratio is rather cheap when compared to the industry. FMS is cheaper than 88.24% of the companies in the same industry.
When comparing the Price/Earnings ratio of FMS to the average of the S&P500 Index (26.50), we can say FMS is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.88, the valuation of FMS can be described as very reasonable.
Based on the Price/Forward Earnings ratio, FMS is valued cheaper than 89.22% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.93, FMS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.86 | ||
| Fwd PE | 9.88 |
4.2 Price Multiples
86.27% of the companies in the same industry are more expensive than FMS, based on the Enterprise Value to EBITDA ratio.
FMS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FMS is cheaper than 90.20% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.81 | ||
| EV/EBITDA | 6.62 |
4.3 Compensation for Growth
FMS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FMS's earnings are expected to grow with 13.20% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y12.88%
EPS Next 3Y13.2%
5. Dividend
5.1 Amount
FMS has a Yearly Dividend Yield of 3.57%.
Compared to an average industry Dividend Yield of 0.58, FMS pays a better dividend. On top of this FMS pays more dividend than 99.02% of the companies listed in the same industry.
FMS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.57% |
5.2 History
The dividend of FMS has a limited annual growth rate of 0.31%.
FMS has paid a dividend for at least 10 years, which is a reliable track record.
FMS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.31%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
FMS pays out 58.83% of its income as dividend. This is a bit on the high side, but may be sustainable.
FMS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.83%
EPS Next 2Y12.88%
EPS Next 3Y13.2%
NYSE:FMS (12/24/2025, 10:52:34 AM)
23.99
+0.03 (+0.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.88%
Inst Owner Change-1.04%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.08B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.93
Price TargetN/A
Short Float %0.18%
Short Ratio1.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.57% |
Yearly Dividend0.69
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years2
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-2.76%
PT rev (3m)-7.17%
EPS NQ rev (1m)1.6%
EPS NQ rev (3m)-4.08%
EPS NY rev (1m)2.19%
EPS NY rev (3m)2.62%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)1.16%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.86 | ||
| Fwd PE | 9.88 | ||
| P/S | 0.61 | ||
| P/FCF | 6.81 | ||
| P/OCF | 4.76 | ||
| P/B | 0.92 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.62 |
EPS(TTM)2.21
EY9.21%
EPS(NY)2.43
Fwd EY10.13%
FCF(TTM)3.52
FCFY14.69%
OCF(TTM)5.04
OCFY21.02%
SpS39.45
BVpS26.01
TBVpS-3.79
PEG (NY)0.5
PEG (5Y)N/A
Graham Number35.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 1.8 |
F-Score5
WACC5.06%
ROIC/WACC0.78
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.52%
EPS Next 2Y12.88%
EPS Next 3Y13.2%
EPS Next 5Y13.73%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.24%
Revenue Next 3Y2.92%
Revenue Next 5Y4.08%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.11%
EBIT Next 3Y29.81%
EBIT Next 5Y18.68%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE-ADR / FMS FAQ
What is the fundamental rating for FMS stock?
ChartMill assigns a fundamental rating of 5 / 10 to FMS.
What is the valuation status of FRESENIUS MEDICAL CARE-ADR (FMS) stock?
ChartMill assigns a valuation rating of 8 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.
How profitable is FRESENIUS MEDICAL CARE-ADR (FMS) stock?
FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.
How financially healthy is FRESENIUS MEDICAL CARE-ADR?
The financial health rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 4 / 10.
What is the expected EPS growth for FRESENIUS MEDICAL CARE-ADR (FMS) stock?
The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to grow by 21.52% in the next year.